ERBB2 and breast cancer: The Ktrans of HER2‐positive breast cancer brain metastases was significantly greater than the Ktrans of HER2‐negative breast cancer brain metastases (0.09 min−1 vs 0.02 min−1, U = 18.00, p = 0.024).